BenevolentAI B

BenevolentAI

AI drug discovery platform

BenevolentAI applies machine learning to biomedical data to identify new drug targets and treatment candidates.

1 tools ·founded 2013 ·London, United Kingdom
Visit BenevolentAI
// founders
Founder
Ken Mulvany

// tools by BenevolentAI